The global hyperthermia treatment for cancer market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Increase in incidence of different types of cancer and rise in diagnosis rate are the key factors boosting the growth of the market. The most common cancers diagnosed in men are prostate, lung, and colorectal cancers which account for an estimated 43% while for women most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in 2020. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective cancer cachexia treatment drugs. For instance, the FY 2019 funds available to the NCI totaled $6.1 billion (includes $400 million in CURES Act funding), reflecting an increase of 3 percent, or $178 million from the previous fiscal year. Under the NCI RPG funding policy for FY 2019. Moreover, in 2019, Cancer Research Society invested more than $145.9 million in cancer research.
Browse the full report of " Global Hyperthermia Treatment for Cancer Market Size, Share & Trends Analysis Report by Application (Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Leukemia, Head and Neck Tumors, and Prostate Cancer), By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, and Short-wave Hyperthermia Device), By End-User (Hospitals, Clinics, Research Institutes, and Cancer Centers), Forecast 2022-2028" at https://www.omrglobal.com/industry-reports/hyperthermia-treatment-for-cancer-market
Apart from that, there are some reasons which may interrupt the growth of the hyperthermia treatment market such as, the high cost of the treatment procedure as compared to other cancer procedures as the average cost for hyperthermia treatment in the U.S. is around US$50,000 for each cancer type. Along with this, the treatment with hyperthermia requires special equipment and expertise which is not widely available across the world.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including Pyrexar Medical Inc., Hydrosun Medizintechnik GmbH, Celsius42 GmbH, Chongqing Haifu medical technology Co. Ltd., Yamamoto Vinita Co., Ltd., Gamida Cell Ltd., and others
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Hyperthermia Treatment for Cancer Market Report Segment
By Application
By Device Type
By End-User
Global Hyperthermia Treatment for Cancer Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World